The relationship of HLA-G 14-bp insertion/deletion genetic polymorphism to the risk of multiple sclerosis and its clinical phenotypes

被引:1
|
作者
Farghaly, Wafaa M. [1 ]
Saad Eldien, Heba M. [2 ,3 ]
Sayed, Mohammed A.
Elnady, Hassan M. [4 ]
Khodeary, Ashraf [5 ]
Abdel-Gawad, Abdelhady R. [5 ]
El-Tallawy, Hamdy N. [1 ]
Abdellatif, Mohammed G. [4 ]
Alhewaig, Hazem K. [4 ]
机构
[1] Assiut Univ, Dept Neurol, Assiut, Egypt
[2] Jouf Univ, Dept Anat, Coll Med, Sakakah, Saudi Arabia
[3] Assiut Univ, Tissue Culture & Mol Biol Ctr, Histol & Cell Biol, Fac Med, Assiut, Egypt
[4] Sohag Univ, Dept Neurol, Fac Med, Sohag, Egypt
[5] Sohag Univ, Dept Clin Pathol, Fac Med, Sohag, Egypt
来源
EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY | 2021年 / 57卷 / 01期
关键词
HLA-G; Multiple sclerosis; Polymorphism; 14-bp insertion; deletion; NATURAL-HISTORY; ASSOCIATION; EXPRESSION; PREVALENCE; FATIGUE; SERUM;
D O I
10.1186/s41983-021-00312-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background Human leukocyte antigen (HLA)-G molecule has been suggested to have a potential immunomodulatory role in multiple sclerosis (MS). Genetic variant sites of HLA-G molecule have been reported to be associated with autoimmune diseases. Identifying the genetic risk factors of MS may help in preventive strategies and anticipating disease progression. The aim of this work was to investigate the effect of HLA-G 14-base-pair insertion/deletion (14-bp INS/DEL) genetic polymorphism on MS risk and clinical characteristics and to observe the clinical characteristics of the MS patients' group. The study included 48 MS patients and 50 cross-matched healthy controls, who were recruited from Sohag and Assiut university hospitals. Genetic testing (14-bp Ins/Del gene polymorphism) using polymerase chain reaction (PCR) was performed for patients and control groups. All patients had a detailed clinical assessment and have undergone measurement of disability using the Expanded Disability Status Scale (EDSS). Results No statistically significant difference was found between MS patients and healthy controls (HC) in genotypic and allelic frequencies of HLA-G 14-bp INS/DEL polymorphism (P=0.305). No significant association was found between HLA-G 14-bp INS/DEL polymorphism genotypes and clinical characteristics or degree of disability of MS patients. The most frequent presenting symptoms of MS were motor symptoms. Fatigue was the most reported symptom along the course of MS disease. Conclusion Although it has been long known that HLA-G represents an important MS susceptibility locus, in this study, no significant relation could be detected between the 14-bp INS/DEL polymorphism genotype and MS susceptibility. MS risk susceptibility may be not linked to a single allele but may depend on the combination of different polymorphic genetic sites. In this study, the lack of genetic susceptibility may be attributed to ethnic factor.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] INCREASED FREQUENCY OF THE 14-BP INSERTION IN HLA-G
    Craenmehr, Moniek H. C.
    Nederlof, Iris
    Cao, Milo
    Anholts, Jacqueline D. H.
    Drabbels, Jos J. M.
    Claas, Frans H. J.
    Heidt, Sebastiaan
    Eikmans, Michael
    HLA, 2018, 91 (05) : 464 - 465
  • [22] 14-BP deletion-insertion polymorphism in the 3′UT region of the HLA-G gene influences HLA-G mRNA stability
    Rousseau, P
    Mouillot, G
    Le Discorde, M
    Marcou, C
    Dausset, J
    Carosella, ED
    Moreau, P
    TISSUE ANTIGENS, 2003, 62 (04): : 353 - 353
  • [23] Genetic association between the HLA-G 14-bp insertion/deletion polymorphism and the recurrent spontaneous abortions in Saudi Arabian women
    Al Omar, S. Y.
    Mansour, L.
    Alkhuriji, A. F.
    Alwasel, S.
    Al-Qahtani, S.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01): : 286 - 293
  • [24] HLA-G 14 bp Deletion/Insertion Polymorphism in Celiac Disease
    Fabris, Annalisa
    Segat, Ludovica
    Catamo, Eulalia
    Morgutti, Marcello
    Vendramin, Anna
    Crovella, Sergio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (01): : 139 - 144
  • [25] Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease
    Zidi, Ines
    Ben Yahia, Hamza
    Bortolotti, Daria
    Mouelhi, Leila
    Laaribi, Ahmed Baligh
    Ayadi, Shema
    Zidi, Nour
    Houissa, Fatma
    Debbech, Radhouane
    Boudabous, Abdellatif
    Najjar, Taoufik
    Di Luca, Dario
    Rizzo, Roberta
    INTERNATIONAL IMMUNOLOGY, 2015, 27 (06) : 289 - 296
  • [26] Lack of association of the HLA-G 14bp insertion/deletion polymorphism with systemic sclerosis
    Veit, T.
    Gutierrez, J.
    Delgado-Canedo, A.
    Bredemeier, M.
    Brenol, J.
    Xavier, R.
    Chies, J.
    TISSUE ANTIGENS, 2008, 72 (03): : 277 - 278
  • [27] Role of 14-bp insertion/deletion polymorphism in HLA-G among Indian women with recurrent spontaneous abortions
    Aruna, M.
    Sirisha, P. V. S.
    Bhaskar, S. Andal
    Tarakeswari, S.
    Thangaraj, K.
    Reddy, B. M.
    TISSUE ANTIGENS, 2011, 77 (02): : 131 - 135
  • [28] HLA-G polymorphism (14-bp exon 8) in psoriasis
    Souza, Cacilda da Silva
    Donadi, Eduardo Antonio
    Cardili, Renata Nahas
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB194 - AB194
  • [29] HLA-G 14-bp insertion/deletion polymorphism and risk of coronavirus disease 2019 (COVID-19) among Iraqi patients
    Ad'hiah, Ali H.
    Al-Bayatee, Noor T.
    HUMAN IMMUNOLOGY, 2022, 83 (06) : 521 - 527
  • [30] The HLA-G 14 bp insertion/deletion polymorphism and its association with soluble HLA-G levels in women with recurrent miscarriages
    Kalotra, V.
    Lall, M.
    Verma, I. C.
    Kaur, A.
    Kaur, A.
    HLA, 2018, 91 (03) : 167 - 174